Towards cervical cancer eradication: Joint force of HPV vaccination and HPV-based cervical cancer screening

Clinical Microbiology and Infection

Volumn 21, Issue 9, 2015, Pages 806-807

  Poljak, M ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Cervical cancer; HPV; Human papillomaviruses; Screening; Vaccination

Indexed keywords

WART VIRUS VACCINE;

CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; DNA DETERMINATION; EDITORIAL; FOLLOW UP; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; PREVALENCE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS; CARCINOMA; COMPLICATION; EARLY CANCER DIAGNOSIS; FEMALE; IMMUNOLOGY; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; UTERINE CERVICAL NEOPLASMS; UTILIZATION;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

CARCINOMA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84940614655     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.05.041     Document Type: Editorial

References (19)

1. Bernard H.U., Burk R.D., Chen Z., van Doorslaer K., zur Hausen H., de Villiers E.M. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401:70-79.
2. Rector A., Van Ranst M. Animal papillomaviruses. Virology 2013, 445:213-223.
3. de Villiers E.M. Cross-roads in the classification of papillomaviruses. Virology 2013, 445:2-10.
4. Bzhalava D., Eklund C., Dillner J. International standardization and classification of human papillomavirus types. Virology 2015, 476:341-344.
5. Kocjan B.J., Bzhalava D., Forslund O., Dillner J., Poljak M. Molecular methods for identification and characterization of novel papillomaviruses. Clin Microbiol Infect 2015, 21:808-816.
6. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
7. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch X., Kummer A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. JPathol 1999, 189:12-19.
8. Arbyn M., Snijders P.J.F., Meijer C.J.L.M., Berkhof H., Cuschieri K., Kocjan B.J., et al. Which high-risk HPV assays fulfil the criteria for use in primary cervical cancer screening?. Clin Microbiol Infect 2015, 21:817-826.
9. Pils S., Joura E.A. From the monovalent to the nine-valent HPV vaccine. Clin Microbiol Infect 2015, 21:827-833.
10. Castle P.E., Schmeler K.M. HPV vaccination: for women of all ages?. Lancet 2014, 384:2178-2180.
11. Arbyn M., Ronco G., Anttila A., Meijer C.J.L.M., Poljak M., Ogilvie G., et al. Evidence regarding HPV testing in secondary prevention of cervical cancer. Vaccine 2012, 30(Suppl.5):F88-F99.
12. Sankaranarayanan R., Nene B.M., Shastri S.S., Jayant K., Muwonge R., Budukh A.M., et al. HPV screening for cervical cancer in Rural India. NEngl J Med 2009, 360:1385-1394.
13. Ronco G., Dillner J., Elfstrom K.M., Tunesi S., Snijders P.J., Arbyn M., et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up off four European randomised controlled trials. Lancet 2014, 383:524-532.
14. Poljak M., Kocjan B.J. Commercially available assays for multiplex detection of alpha human papillomaviruses. Expert Rev Anti Infect Ther 2010, 8:1139-1162.
15. Poljak M., Cuzick J., Kocjan B.J., Iftner T., Dillner J., Arbyn M. Nucleic acid tests for the detection of human papillomaviruses. Vaccine 2012, 30(Suppl.5):F100-F106.
16. Meijer C.J.L.M., Castle P.E., Hesselink A.T., Franco E.L., Ronco G., Arbyn M., et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 2009, 124:516-520.
17. Joura E.A., Giuliano A.R., Iversen O.E., Mehlsen M.M., Moreira E.D., Ngan Y., et al. A9-valent HPV vaccine against infection and intraepithelial neoplasia in women. NEngl J Med 2015, 372:711-723.
18. Garland S.M., Molesworth E.G., Machalek D.A., Cornall A., Tabrizi S.N. How to best measure the effectiveness of male human papillomavirus vaccine programmes?. Clin Microbiol Infect 2015, 21:834-841.
19. Isidean S.D., Coutlee F., Franco E.L. Cobas 4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens. Expert Rev Mol Diagn 2014, 14:5-16.